Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
12/2000
12/28/2000WO2000061551A3 Pyrimidine-2-one derivatives as integrin receptor ligands
12/28/2000WO2000056353A3 A uro-genital condition treatment system
12/28/2000WO2000055162A3 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
12/28/2000WO2000043495A3 33 human secreted proteins
12/28/2000WO2000043373A3 Kinase inhibitors
12/28/2000WO2000035465A3 Oral administration of lactobacillus for the treatment and prevention of urogenital infection
12/28/2000DE19929065A1 Synergistic drug combination, especially for treating cardiovascular diseases associated with metabolic disorders, comprising bi- or tricyclic aza-heterocyclic MTP inhibitor and HMG-CoA reductase inhibitor
12/28/2000DE19922662C1 Transdermales therapeutisches System (TTS) Tolterodin enthaltend Transdermal therapeutic system (TTS) containing tolterodine
12/28/2000DE19917705C1 Mittel zur Therapie von Hyperphosphatämie Means for therapy of hyperphosphatemia
12/28/2000CA2377698A1 Dihydropyrazine derivatives as npy antagonists
12/28/2000CA2377524A1 Novel anti-allergic agents
12/28/2000CA2377288A1 Macrophage scavenger receptor antagonists
12/28/2000CA2376284A1 A method for the prophylaxis and/or treatment of medical disorders
12/28/2000CA2376155A1 Pharmaceutical composition for oral use
12/28/2000CA2375493A1 Human transport proteins
12/28/2000CA2375407A1 Rna metabolism proteins
12/28/2000CA2375282A1 Potassium channel openers
12/28/2000CA2375268A1 Indoloazepines as vasopressin receptor antagonists
12/28/2000CA2373497A1 Chromeno[4,3,2-de]isoquinolines as potent dopamine receptor ligands
12/28/2000CA2373375A1 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions
12/28/2000CA2371924A1 Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
12/27/2000EP1063293A2 Transforming growth factor alpha H1
12/27/2000EP1063292A2 DNA encoding human alpha 1 adrenergic receptors and uses thereof
12/27/2000EP1063291A2 DNA encoding human alpha 1 adrenergic receptors and uses thereof
12/27/2000EP1062229A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
12/27/2000EP1062210A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors
12/27/2000EP1061926A2 Heterocyclic compounds, their production and use as tachykinin receptor antagonists
12/27/2000EP1061909A1 Keto acid salts and amine derivatives, and their use for preparing medicines
12/27/2000EP1061803A1 Novel compositions of eprosartan
12/27/2000CN1278251A Novel carboxylic acid derivatives which carry amide side chains, prodn. of same, and use as endothelin receptor antagonists
12/27/2000CN1278247A Alpha-hydroxy, amino and -fluoro derivatives of beta-sulphenyl hydroxamic acids matrix metalloproteinases inhibitors
12/27/2000CN1278007A Human interleukin 2 derivatives and human heart sodium medium fusion gene, its protein products and use thereof
12/27/2000CN1277857A Traditional Chinese medicine for tonifying spleen and expelling dampness
12/27/2000CN1059809C Chroic nephritis pills
12/26/2000US6166219 Treatment of diabetes and related disorders
12/26/2000US6166193 Nucleotide sequence which encodes g-protein coupled receptor; for the treatment and prevention of bacterial, fungal, protozoan and viral infections; for use in gene therapy
12/26/2000US6166061 Methods and formulations for modulating the human sexual response
12/26/2000US6166055 Antiinflammatory agents
12/26/2000US6166049 A treatment and/or prophylaxis of hyperglycaemia, pre-diabetic insulin resistance syndrome by administering an agonist of peroxisome proliferator-activated receptor to stimulate fatty oxidation
12/26/2000US6165751 HLDAT86 polynucleotides
12/21/2000WO2000077255A1 49 human secreted proteins
12/21/2000WO2000077237A1 49 human secreted proteins
12/21/2000WO2000077226A1 22025, a novel human cyclic nucleotide phosphodiesterase
12/21/2000WO2000077179A2 Human poly(adp-ribose) polymerase 2 materials and methods
12/21/2000WO2000077022A1 50 human secreted proteins
12/21/2000WO2000077009A1 DITHIEPINO[6,5-b]PYRIDINES, AND RELATED COMPOSITIONS AND METHODS
12/21/2000WO2000076984A2 Novel compounds, their use and preparation
12/21/2000WO2000076980A1 Novel nitrogen-contaiing heterocyclic derivatives or salts thereof
12/21/2000WO2000076538A1 Feline calicivirus isolated from cat urine and vaccines thereof
12/21/2000WO2000076515A1 Il-8 receptor antagonists
12/21/2000WO2000076503A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000WO2000053628A3 Genes encoding human potassium channel proteins
12/21/2000WO2000047580A3 Phenyl urea and phenyl thiourea derivatives
12/21/2000WO2000044710A3 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
12/21/2000WO2000038660A3 Use of bisphosphonates for the prevention and treatment of infectious processes
12/21/2000CA2383048A1 49 human secreted proteins
12/21/2000CA2382748A1 50 human secreted proteins
12/21/2000CA2382735A1 49 human secreted proteins
12/21/2000CA2377391A1 Il-8 receptor antagonists
12/21/2000CA2377153A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000CA2376717A1 Human poly(adp-ribose) polymerase 2 materials and methods
12/21/2000CA2375878A1 Dithiepino[6,5-b]pyridines, and related compositions and methods
12/20/2000EP1060240A1 New agent
12/20/2000EP1060181A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases
12/20/2000EP1060167A1 Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed et a?/et b?-receptor antagonists
12/20/2000EP1059943A1 Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles
12/20/2000EP0938309A4 Methods for in vivo reduction of iron levels and compositions useful therefor
12/20/2000EP0842148B1 Benzenesulphonamide derivatives, preparation thereof and therapeutical uses thereof
12/20/2000CN1277613A Poly (ADP-ribose) polymerase ('PARP') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
12/20/2000CN1277038A Nephropathy curing capsule
12/20/2000CN1059580C Sikang yangsheng health-care tablet
12/19/2000US6162831 Prevention of gout; cardiovascular disorders
12/19/2000US6162819 Pyrazole derivatives, their preparation and their use in pharmaceuticals
12/19/2000US6162818 Respiratory system disorders; crohn's disorder; cardiovascular disorders
12/19/2000US6162790 Oligopeptides
12/19/2000US6162444 Cosmetic or pharmaceutical compositions
12/19/2000CA2050291C Combination therapy for the treatment of estrogen sensitive diseases
12/14/2000WO2000075375A1 26 human secreted proteins
12/14/2000WO2000075319A1 Modified chimeric polypeptides with improved pharmacokinetic properties
12/14/2000WO2000075318A1 Phospholipid transfer protein
12/14/2000WO2000075290A1 Method for multiplying stem cells
12/14/2000WO2000075186A1 Neuromedin b and somatostatin receptor agonists
12/14/2000WO2000075175A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000WO2000075163A1 Angiogenic proteins and uses thereof
12/14/2000WO2000075107A2 Bradykinin receptor antagonists
12/14/2000WO2000074742A1 Devices and compounds for treating arterial restenosis
12/14/2000WO2000074724A2 Conjugates comprising cytokines and nucleic acids for treating proliferating cells
12/14/2000WO2000074718A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000WO2000074710A2 Methods for treating diabetes
12/14/2000WO2000074706A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000WO2000074697A1 Formulations containing cranberry fruit, dl-methionine, and chinese herbs
12/14/2000WO2000074666A2 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidaemia and hyperuricaemia
12/14/2000WO2000050562A3 Dna encoding snorf25 receptor
12/14/2000WO2000047284A3 Novel use of orexin receptor antagonists
12/14/2000WO2000046228A3 Pyrrolobenzodiazepine carboxyamide vasopressin agonists
12/14/2000WO2000046225A3 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
12/14/2000WO2000044763A3 Compositions for treating inflammatory response
12/14/2000WO2000043032A3 Baff, inhibitors thereof and their use in the modulation of b-cell response
12/14/2000CA2751187A1 Use of (-)(3-trihalomethylphenoxy)(4-halophenyl)acetic acid and derivatives thereof for treatment of hyperuricemia
12/14/2000CA2383828A1 26 human secreted proteins
1 ... 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 ... 562